Gut Bacteria Causally Linked to Brain White Matter Health via Genetic Analysis
First Mendelian randomization study finds 17 bacterial taxa causally influence white matter integrity, connectivity, and stroke risk.
Summary
Researchers used Mendelian randomization — a method that uses genetic variants to establish causality — to test whether specific gut bacteria influence brain white matter health. Analyzing GWAS data from up to 50,970 participants, they identified 17 bacterial taxa with causal effects on white matter hyperintensities, microstructure, or connectivity. Four bacteria were linked to white matter lesions, three showed consistent effects on microstructure across multiple metrics, and 12 associations were found with white matter connectivity. Notably, certain bacteria appeared protective against ischemic stroke and ALS, while one genus increased risk for a rare autoimmune nerve disease. The findings suggest the gut-brain axis may directly shape brain structural integrity.
Detailed Summary
White matter — the brain's communication highway made of myelinated axons — is increasingly recognized as a key target in neurological aging and disease. Damage to white matter, visible as white matter hyperintensities (WMHs) on MRI, is associated with cognitive decline, stroke, and dementia. Meanwhile, the gut microbiome has emerged as a powerful modulator of brain health via immune, neuroendocrine, and vagal pathways. Yet whether specific gut bacteria causally affect white matter integrity had never been rigorously tested — until this study.
The researchers conducted a two-sample Mendelian randomization (MR) analysis using GWAS summary statistics from four major datasets. Gut microbiota genetic data came from the MiBioGen consortium (N=18,340), covering 211 bacterial taxa. White matter hyperintensity data came from the CHARGE/UK Biobank consortium (N=50,970). White matter microstructure data were drawn from 31,356 UK Biobank participants using diffusion MRI metrics including DTI and NODDI. White matter connectivity data came from 26,333 UK Biobank participants. Thirteen neurological disease GWAS datasets were also included, covering stroke subtypes, MS, ALS, Alzheimer's, Parkinson's, and rare autoimmune conditions.
Four bacterial taxa showed statistically significant causal associations with WMH burden after Bonferroni correction (p<2.55×10⁻⁴): class Melainabacteria, order Gastranaerophilales, family Alcaligenaceae, and genus Ruminiclostridium 6. Three additional taxa demonstrated consistent effects across multiple white matter microstructure metrics, suggesting broad influence on axonal integrity and myelination. Twelve significant associations were identified between bacterial taxa and white matter connectivity pathways, with genes CPNE1, PIGU, MED22, SURF6, DOCK10, and COPS3 emerging as mediating candidates through transcriptomic MR and SMR/HEIDI analyses.
For neurological disease outcomes (Bonferroni threshold p<2.94×10⁻³), several striking findings emerged. Family Clostridiaceae 1 showed a protective effect against ischemic stroke. Genus Barnesiella was protective against both ischemic stroke and small vessel stroke, but paradoxically increased risk for neuromyelitis optica spectrum disorder (NMOSD) and its AQP4-IgG+ subtype. Order Desulfovibrionales and family Desulfovibrionaceae were protective against cardioembolic stroke. Genus Ruminococcus gnavus group showed a protective effect against ALS. These findings survived pleiotropy testing via MR-Egger and MR-PRESSO, and heterogeneity was addressed using random-effects models where Cochran's Q indicated significant variance.
The study's functional mapping layer adds mechanistic depth: by mapping significant SNPs to genes via FUMA and then running cis-eQTL-based transcriptomic MR using eQTLGEN data (31,684 blood samples), the authors identified specific genes through which gut bacteria may influence white matter connectivity. This multi-layered approach — from bacterial taxa to SNPs to gene expression to brain imaging phenotypes — represents a methodological advance over prior gut-brain MR studies. Limitations include reliance on mixed-sex European-ancestry cohorts without sex-stratified data, the inherent inability of MR to capture dynamic microbiome changes over time, and the fact that bacterial taxa GWAS were conducted at a single time point.
Key Findings
- Four bacterial taxa (class Melainabacteria, order Gastranaerophilales, family Alcaligenaceae, genus Ruminiclostridium 6) showed significant causal associations with white matter hyperintensity burden (p<2.55×10⁻⁴)
- Three bacterial taxa demonstrated consistent causal effects across multiple white matter microstructure metrics (DTI/NODDI-based), suggesting broad influence on myelination
- 12 significant associations identified between gut bacterial taxa and white matter connectivity pathways in 26,333 UK Biobank participants
- Family Clostridiaceae 1 showed a protective causal effect against ischemic stroke (p<2.94×10⁻³ Bonferroni threshold)
- Genus Barnesiella was protective against ischemic stroke and small vessel stroke but increased risk for AQP4-IgG+ neuromyelitis optica spectrum disorder
- Genus Ruminococcus gnavus group showed a protective causal effect against ALS; order Desulfovibrionales and family Desulfovibrionaceae were protective against cardioembolic stroke
- Transcriptomic MR and SMR/HEIDI analyses identified genes CPNE1, PIGU, MED22, SURF6, DOCK10, and COPS3 as significant mediators linking gut bacteria to white matter connectivity
Methodology
Two-sample Mendelian randomization using GWAS summary statistics from MiBioGen (N=18,340, 211 bacterial taxa), CHARGE/UK Biobank WMH data (N=50,970), UK Biobank white matter microstructure (N=31,356) and connectivity (N=26,333) datasets, and 13 neurological disease GWAS. SNPs were selected at p<1×10⁻⁵ with LD clumping (R²<0.001, 10,000 kb window) and F-statistic>10. Primary analysis used inverse-variance weighted method; secondary methods included weighted median, MR-Egger, weighted mode, and simple mode. Pleiotropy was assessed via MR-Egger intercept and MR-PRESSO; Bonferroni correction applied (p<2.55×10⁻⁴ for white matter outcomes; p<2.94×10⁻³ for disease outcomes). Functional mapping used FUMA with eQTLGEN cis-eQTL data for transcriptomic MR.
Study Limitations
All GWAS datasets were derived from mixed-sex European-ancestry cohorts, limiting generalizability to other ethnicities and precluding sex-stratified analyses. MR captures genetically predicted long-term bacterial abundance rather than dynamic microbiome changes, and cannot account for temporal or environmental shifts in gut composition. The NMOSD and AQP4-IgG+ NMOSD datasets were small (N=546 and N=526 respectively), which may limit statistical power for those specific disease associations. No competing financial interests were declared.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
